IHS Chemical Week

Chemical Week Magazine :: Departments :: Vital Statistics

New Route to Hepatitis Drug

1:38 PM MDT | January 17, 2007 | Chemical Week Editorial Staff

Researchers at Imperial College, part of the University of London, say they have identified a novel synthetic route to produce pegylated interferon, a drug currently produced by Roche to treat hepatitis C. The product developed by the Imperial College researchers would not be covered by Roche’s patent, which covers production of interferon coated with...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa